Funding for this research was provided by:
Innovate UK (104232)
Received: 1 July 2020
Accepted: 11 November 2020
First Online: 8 December 2020
: O.L.A. declares personal fees from Gilead Sciences Ltd. and GSK. M.J.C. has received personal fees from Astellas, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centred Outcomes Research Institute (PCORI) outside the submitted work. The remaining authors declare no competing interests.